Clinical Trials Browser

Phase 1/2 × Palonosetron × Clear all

NCT01046240 2015-01-27

Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy

Phase 1/2 Completed

Vomiting

NCT00412425 2012-05-04

Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting

Phase 1/2 Completed

30 enrolled 4 charts

Anorexia, Melanoma, Nausea, Vomiting, Weight Loss